Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...
Over 2 million people were included in new research to test these drugs against 175 different health outcomes.
While weight-loss drugs were linked to lower risk of some conditions, they were also associated with some adverse health ...
A new drug to potentially treat depression and neurodegenerative diseases, such as dementia or Parkinson’s, is being ...
Recent research reveals that weight-loss injections reduce the risk of 42 health conditions in people with diabetes, ...
The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...
Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...
Researchers have found links to multiple new benefits – and new side effects – in a study of weight-loss drugs such as ...
A major new study has highlighted significant health risks associated with popular weight loss injections such as Ozempic, ...
By 2060, new dementia cases per year could double to one million because of the growing population of older Americans, a ...